Chin Lee
Technik-/Wissenschafts-/F&E-Leiter bei ALLAKOS INC.
Vermögen: 413 750 $ am 31.05.2024
Profil
Dr. Chin Lee, MD, is a Chief Medical Officer at Allakos, Inc. Dr. Lee was previously employed as a Chief Medical Officer by Connect Biopharma Holdings Ltd., an Associate Medical Director-Immunoscience Group by Abbott Biotech, Inc., a Global Senior Medical Director-Immunology by Eli Lilly & Co., a Group Medical Director by Genentech, Inc., and a Chief Medical Officer & Head-Clinical Science by Theravance Biopharma, Inc. He received his undergraduate degree from The University of North Carolina at Chapel Hill, a graduate degree from Northwestern University and a doctorate degree from The University of North Carolina at Chapel Hill.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ALLAKOS, INC.
0,37% | 16.02.2024 | 331 000 ( 0,37% ) | 413 750 $ | 31.05.2024 |
Aktive Positionen von Chin Lee
Unternehmen | Position | Beginn |
---|---|---|
ALLAKOS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Chin Lee
Unternehmen | Position | Ende |
---|---|---|
Abbott Biotech, Inc. | Corporate Officer/Principal | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
THERAVANCE BIOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
CONNECT BIOPHARMA HOLDINGS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Chin Lee
Northwestern University | Graduate Degree |
The University of North Carolina at Chapel Hill | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
ALLAKOS INC. | Health Technology |
THERAVANCE BIOPHARMA, INC. | Health Technology |
CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Abbott Biotech, Inc. |